Drug release from irradiated PLGA and PLLA multi-layered films

Journal of Pharmaceutical Sciences

Volumn 99, Issue 7, 2010, Pages 3060-3071

  Loo, Say Chye Joachim ^a   Tan, Zhi Ying Serlin ^a   Chow, Yi Jun ^a   Lin, Siew Ling Ivy ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Biodegradable polymers; Controlled release; Materials science; Polymeric drug delivery systems; Water sorption

Indexed keywords

BIOMATERIAL; LIDOCAINE; POLYGLACTIN; POLYLACTIDE; POLYMER;

ARTICLE; BIOFILM; BIOMEDICAL ENGINEERING; CONTROLLED RELEASE FORMULATION; DEGRADATION; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELUTION; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; IRRADIATION; NANOFABRICATION; SOLUBILITY; SURFACE PROPERTY; WATER ABSORPTION;

EID: 77953316516     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22079     Document Type: Article

References (46)

1. Parveen S, Sahoo SK. 2008. Polymeric nanoparticles for cancer therapy. J Drug Target 16:108-123.
2. Mohamed F, van der Walle CF. 2008. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci 97:71-87.
3. Raman C, McHugh AJ. 2005. A model for drug release from fast phase inverting injectable solutions. J Control Release 102:145-157.
4. Xie JW, Tan JC, Wang CH. 2008. Biodegradable films developed by electrospray deposition for sustained drug delivery. J Pharm Sci 97:3109-3122.
5. Loo SCJ, Tan WLJ, Khoa SM, Chia NK, Venkatraman S, Boey F. 2008. Hydrolytic degradation characteristics of irradiated multi-layered PLGA films. Int J Pharm 360:228-230.
6. Thakur RA, Florek CA, Kohn J, Michniak BB. 2008. Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing. Int J Pharm 364:87-93.
7. Ramchandani M, Pankaskie M, Robinson D. 1997. The influence of manufacturing procedure on the degradation of poly (lactide-co-glycolide) 85:15 and 50:50 implants. J Control Release 43:161-173.
8. Wu XS. 1995. Synthesis and properties of biodegradable lactic/glycolic acid polymers. In: Wise DL, Trantolo DJ, Altobelli DE, Yaszemski MJ, Gresser JD, Schwartz ER, editors. Encyclopedic handbook of biomaterials and bioengineering. New York: Marcel Dekker. pp 1015-1054.
9. Athanasiou KA, Niederauer GG, Agrawal CM. 1996. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid copolymers. Biomaterials 17:93-102.
10. Vert M, Li SM, Spenlehauer G, Guerin P. 1992. Bioresorb-ability and biocompatibility of aliphatic polyesters. J Mater Sci Mater Med 3:432-446.
11. Perugini P, Genta I, Conti B, Modena T, Pavanetto F. 2003. Periodontal delivery of ipriflavone: New chitosan/PLGA film delivery system for a lipophilic drug. Int J Pharm 252:1-9. (Pubitemid 36126609)
12. Agarwal RK, Robinson DH, Maze GI, Reinhardt RA. 1993. Development and characterization of tetracycline-poly(lactide glycolide) films for the treatment of periodontitis. J Control Release 23:137-146.
13. Webber WL, Lago F, Thanos C, Mathiowitz E. 1998. Characterization of soluble, salt-loaded, degradable PLGA films and their release of tetracycline. J Biomed Mater Res 41:18-29. (Pubitemid 28255890)
14. Huang SF, Chen JL, Yeh MK, Chiang CH. 2005. Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects. J Ocul Pharmacol Ther 21:445-453.
15. Dorta MJ, Oliva A, Munguia O, Llabres M, Farina JB. 2002. In vitro release of fluoropyrimidines from PLGA film implants. J Pharm Pharmacol 54:757-763.
16. Dong Y, Zhang Z, Feng SS. 2008. D-alpha-Tocopheryl polyethylene glycol 1000 succinate (TPGS) modified poly(L-lactide) (PLLA) films for localized delivery of paclitaxel. Int J Pharm 350:166-171. (Pubitemid 351146680)
17. Sternberg K, Kramer S, Nischan C, Grabow N, Langer T, Hennighausen G, Schmitz KP. 2007. In vitro study of drugeluting stent coatings based on poly(L-lactide) incorporating cyclosporine A-drug release, polymer degradation and mechanical integrity. J Mater Sci Mater Med 18:1423-1432.
18. Westedt U, Wittmar M, Hellwig M, Hanefeld P, Greiner A, Schaper AK, Kissel T. 2006. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings. J Control Release 111:235-246.
19. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H. 2000. Initial and 6-month results of biodegradable poly L-lactic acid coronary stents in humans. Circulation 102:399-404.
20. Jackson JK, Smith J, Letchford K, Babiuk KA, Lindsay M, Signore P, Hunter WL, Wang KY, Burt HM. 2004. Characterization of perivascular poly (lactic-co-glycolic acid) films containing paclitaxel. Int J Pharm 283:97-109.
21. Wang XT, Venkatraman S, Boey F, Loo JSC, Tan LP. 2007. Effects of controlled-released sirolimus from polymer matrices on human artery smooth muscle cells. J Biomater Sci Polym Ed 18:1401-1414. (Pubitemid 47622372)
22. Lim HJ, Nam HY, Lee BH, Kim DJ, Ko JY, Park JS. 2007. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Biotechnol Prog 23:693-697.
23. Wang XT, Venkatraman SS, Boey FYC, Loo JSC, Tan LP. 2006. Controlled release of sirolimus from a multilayered PLGA stent matrix. Biomaterials 27:5588-5595.
24. Gumusderelioglu M, Deniz G. 2000. Sustained release of mitomycin-C from poly(DL-lactide)/poly(DL-lactide-co-glycolide) films. J Biomater Sci Polym Ed 11:1039-1050. (Pubitemid 32062980)
25. Klose D, Siepmann F, Elkhamz K, Siepmann J. 2008. PLGA-based drug delivery systems: Importance of the type of drug and device geometry. Int J Pharm 354:95-103. (Pubitemid 351410450)
26. Miao PK, Zhao CN, Xu GL, Fu Q, Tang WR, Zeng K, Wang YP, Zhou HF, Yang G. 2009. Degradation of Poly(D,L-lactic acid)-b-poly(ethylene glycol)-b-poly(D,L- lactic acid) Copolymer by Electron Beam Radiation. J Appl Polym Sci 112:2981-2987.
27. Loo SCJ, Tan HT, Ooi CP, Boey YCF. 2006. Hydrolytic degradation of irradiated and non-irradiated PLLA. Acta Biomater 2:287-296.
28. Loo SCJ, Ooi CP, Boey YCF. 2005. Influence of electron beam radiation on the hydrolytic degradation behaviour of poly(lactide-co-glycolide) (PLGA). Biomaterials 26:3809-3817. (Pubitemid 40038773)
29. Leonard DJ, Pick LT, Farrar DF, Dickson GR, Orr JF, Buchanan FJ. 2009. The modification of PLA and PLGA using electron-beam radiation. J Biomed Mater Res A 89A:567-574.
30. Chia NK, Venkatraman SS, Boey FYC, Cadart S, Loo JSC. 2008. Controlled degradation of multi-layered PLGA films using electron beam irradiation. J Biomed Mater Res A 84A:980-987. (Pubitemid 351295008)
31. Alexis F. 2004. Factors affecting the degradation and drugrelease mechanism of poly(lactic acid) and poly[(lactic acid) -co- (glycolic acid)]. Polym Int 54:36-46.
32. Abdul S,Poddar SS. 2004.Aflexible technology formodified release of drugs: Multi layered tablets. J Control Release 97:393-405.
33. Chen MC, Liang HF, Chiu YL, Chang Y, Wei HJ, Sung HW. 2005. A novel drug eluting stent spray-coated with multi-layers of collagen and sirolimus. J Control Release 108:178-189. (Pubitemid 41476685)
34. Conte U, Maggi L, Colombo P, Lamanna A. 1993. Multilayered hydrophilic matrices as constant release devices (Geomatrix™ systems). J Control Release 26:39-47. (Pubitemid 23204077)
35. Loo SCJ, Ooi CP, Tan ML, Boey YCF. 2005. Isothermal annealing of PLGA and its effect on radiation degradation. Polym Int 54:636-643.
36. Frank A, Rath SK, Venkatraman SS. 2005. Controlled release from bioerodible polymers: Effect of drug type and polymer composition. J Control Release 102:333-344. (Pubitemid 40093757)
37. Loo SCJ, Ooi CP, Boey YCF. 2004. Radiation effects on poly(-lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA). Polym Deg Stab 83:259-265.
38. Niwa T, Takeuchi T, Hino T, Kunou N, Kawashima Y. 1993. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D,L lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Control Release 25:89-98. (Pubitemid 23168633)
39. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70:1-20. (Pubitemid 32144788)
40. Göpferich A, Tessmar J. 2002. Polyanhydride degradation and erosion. Adv Drug Deliv Rev 54:911-931.
41. Chasin M, Domb A, Ron E, Mathiowitz E, Langer R, Leong K, Laurencin C, Brem H, Grossman S. 1990. Polyanhydrides as drug delivery systems. Drug Pharm Sci 45:43-70.
42. Higuchi T. 1963. Mechanism of sustained action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145-1149.
43. Higuchi T. 1961. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 50:874-875.
44. Tatai A, Aigner Z, Eros I, Kata M. 2007. Preparation and investigation of mixtures containing lidocaine base and beta-cyclodextrin. J Inclusion Phenom Macrocyclic Chem 59:105-113.
45. Loo SCJ, Ooi CP, Boey FYC. 2005. Degradation of poly(lactideco-glycolide) (PLGA) and poly(L-lactide) (PLLA) by electron beam radiation. Biomaterials 26:1359-1367.
46. Klose D, Siepmann F, Elkharraz K, Krenzlin S, Siepmann J. 2006. How porosity and size affect the drug release mechanisms from PLIGA-based microparticles. Int J Pharm 314:198-206.